PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

METTL3 drives oral cancer by blocking tumor-suppressing gene

“[…] we report that METTL3, an oncogene regulates the expression of SMAD4, a tumor-suppressor via miR-146a-5p, thus unveiling a novel regulatory axis of METTL3/miR-146a-5p/SMAD4 in OSCC, which can potentially have therapeutic implications”

2025-05-09
(Press-News.org)

“[…] we report that METTL3, an oncogene regulates the expression of SMAD4, a tumor-suppressor via miR-146a-5p, thus unveiling a novel regulatory axis of METTL3/miR-146a-5p/SMAD4 in OSCC, which can potentially have therapeutic implications.”

BUFFALO, NY – May 9, 2025 – A new research paper was published in Oncotarget, Volume 16, on May 8, 2025, titled “METTL3 promotes oral squamous cell carcinoma by regulating miR-146a-5p/SMAD4 axis.”

In this study, researchers Jayasree Peroth Jayaprakash, Pragati Karemore, and Piyush Khandelia from the Birla Institute of Technology and Science, India, discovered that a molecule called METTL3 contributes to the development and spread of oral squamous cell carcinoma (OSCC). The study shows that METTL3 increases the levels of a small RNA molecule called miR-146a-5p, which blocks SMAD4, a key tumor-suppressing gene. These findings help explain why oral cancers are difficult to treat and may offer a new target for more effective therapies.

Oral squamous cell carcinoma is a common and aggressive cancer affecting the mouth and throat. It has a high death rate, mainly due to late detection, treatment resistance, and the cancer’s ability to invade nearby tissues. In this study, the researchers focused on METTL3, an enzyme that adds chemical tags known as m6A marks to RNA, which change how genetic information is used by cells. They found that METTL3 is unusually active in OSCC cells, causing an increase in miR-146a-5p. This molecule, in turn, blocks the function of SMAD4, which helps control how cells grow and die in our bodies.

“METTL3, the primary m6A RNA methyltransferase, is significantly upregulated in OSCC cells leading to increased global m6A levels.”

When METTL3 was reduced or chemically blocked, miR-146a-5p levels dropped and SMAD4 levels increased. This shift slowed the growth of cancer cells, increased their death, and made them less likely to spread. When researchers reintroduced miR-146a-5p or lowered SMAD4 levels again, the cancer-promoting behavior returned. These results show that the METTL3–miR-146a-5p–SMAD4 pathway plays a key role in OSCC.

The findings open up new possibilities for treatment. Drugs that block METTL3 or miR-146a-5p or that restore SMAD4 could slow or stop tumor growth. One such drug, STM2457, which targets METTL3, has already shown promise in lab studies. As research progresses, targeting this molecular pathway may offer a new strategy in treating OSCC.

This discovery improves our understanding of how OSCC develops and avoids the body’s defenses. By interfering with this newly discovered pathway, future treatments may become more successful, improving survival rates and quality of life for people with this disease.

Continue reading: DOI: https://doi.org/10.18632/oncotarget.28717

Correspondence to: Piyush Khandelia – piyush.khandelia@hyderabad.bits-pilani.ac.in 

Keywords: cancer, oral cancer, m6A RNA methylation, METTL3, miR-146a-5p, SMAD4

Click here to sign up for free Altmetric alerts about this article.

About Oncotarget:  

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Oncotarget is indexed and archived by PubMed/Medline, PubMed Central, Scopus, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).

To learn more about Oncotarget, visit Oncotarget.com and connect with us on social media:

X
Facebook
YouTube
Instagram
LinkedIn
Pinterest
Spotify, and available wherever you listen to podcasts

Click here to subscribe to Oncotarget publication updates.

For media inquiries, please contact media@impactjournals.com.  

END



ELSE PRESS RELEASES FROM THIS DATE:

Switch to two-point rating scales to reduce racism in performance reviews, research suggests

2025-05-09
 Toronto - The plumber has just left after fixing that leaky basement pipe. Ping – a phone alert asks you to rate their service. Hmm -- if it wasn’t an outright terrible job, do you give them three, four or five stars? New research from the University of Toronto’s Rotman School of Management shows that a multi-point system like that is prone to subtle, often unconscious, racial bias -- yet with significant financial consequences for non-white workers. Using data from a real-life online home maintenance matching service, researchers showed white workers ...

The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: May 9, 2025

2025-05-09
Reston, VA (May 9, 2025)—New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society of Nuclear Medicine and Molecular Imaging, an international scientific and medical organization dedicated to advancing nuclear medicine, molecular imaging, and theranostics—precision medicine that allows diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes. Summaries of the newly published research articles are provided below. New Brain Imaging Tool Targets Key Enzyme in Mental Health Scientists have developed a promising new PET imaging compound, 11C-ZTP-1, to visualize ...

Stability solution brings unique form of carbon closer to practical application

2025-05-09
UNIVERSITY PARK, Pa. — Carbyne, a one-dimensional chain of carbon atoms, is incredibly strong for being so thin, making it an intriguing possibility for use in next-generation electronics, but its extreme instability causing it to bend and snap on itself made it nearly impossible to produce at all, let alone produce enough of it for advanced studies. Now, an international team of researchers, including from Penn State, may have a solution.   The research team has enclosed carbyne in single-walled carbon nanotubes — tiny, tube-shaped ...

New research illustrates the relationship between moral outrage on social media and activism

2025-05-09
A new study published in Social Psychological and Personality Science examines how expressions of moral outrage on social media are linked to online activism, specifically petition signing behavior. A research team led by Dr. Stefan Leach from Lancaster University analyzed over 1.2 million posts on X (formerly Twitter) containing links to nearly 25,000 petitions on Change.org. The findings reveal a surprising disconnect: while expressions of moral outrage significantly increase a post's virality (likes and reposts), they ...

New enzyme capable of cleaving cellulose should revolutionize biofuel production

2025-05-09
The deconstruction of cellulose is essential for the conversion of biomass into fuels and chemicals. But cellulose, the most abundant renewable polymer on the planet, is extremely recalcitrant to biological depolymerization. Although composed entirely of glucose units, its crystalline microfibrillar structure and association with lignin and hemicelluloses in plant cell walls make it highly resistant to degradation. As a result, its degradation in nature is slow and requires complex enzymatic systems. The deconstruction ...

Krebs von den Lungen-6 as a biomarker for distinguishing between interstitial lung disease and interstitial lung abnormalities based on computed tomography findings

2025-05-09
Background: Krebs von den Lungen-6 (KL-6), predominantly expressed by type II alveolar cells, is linked to the prognosis and severity of interstitial lung disease (ILD). This investigation sought to explore the relationship between KL-6 concentrations and the presence of ILD versus interstitial lung abnormalities (ILA). Methods: This single-center retrospective study included 147 patients who were suspected of ILD and underwent KL-6 testing between October 2022 and March 2023. Epidemiological and clinical details of the patients, including the outcomes of pulmonary function tests and computed tomography findings, were retrospectively extracted from electronic medical records. Results: The ...

Chimpanzee groups drum with distinct rhythms

2025-05-09
New research from a team of cognitive scientists and evolutionary biologists finds that chimpanzees drum rhythmically, using regular spacing between drum hits. Their results, publishing in the Cell Press journal Current Biology on May 9, show that eastern and western chimpanzees—two distinct subspecies—drum with distinguishable rhythms. The researchers say these findings suggest that the building blocks of human musicality arose in a common ancestor of chimpanzees and humans. “Based on our previous work, we expected that western chimpanzees would use more hits and drum more ...

Wasp mums use remarkable memory when feeding offspring

2025-05-09
Wasp mothers have stunning brainpower when it comes to feeding their young, new research shows. Digger wasps make a short burrow for each egg, stocking it with food and returning a few days later to provide more. The study reveals that mother wasps can remember the locations of up to nine separate nests at once, rarely making mistakes despite the fact nests are dug in bare sand containing hundreds belonging to other females. Mothers feed their young in age order, adjusting the order if one dies, and they can even delay feeding offspring that had ...

Americans’ use of illicit opioids is higher than previously reported

2025-05-09
More Americans use illicit opioids such as fentanyl than previously estimated, highlighting the need for better methods to understand the depths of the opioid crisis, according to a new study. A survey of American adults found that 11% reported illicit opioid use within the past 12 months and 7.5% reported use of illicitly produced fentanyl during the same period, rates that are more than 20 times higher than estimates from a large federal study that annually asks Americans about their use of illicit drugs. Researchers say the findings add to the evidence that government counts may significantly underestimate illicit drug use and suggest ...

Estimates of illicit opioid use in the U.S.

2025-05-09
About The Study: In this national survey of 1,515 adults conducted in June 2024, 166 respondents (11.0%) reported illicit opioid use and 114 (7.5%) reported illicitly manufactured fentanyl use within the past 12 months. These rates are much higher than previously reported estimates. The findings highlight the need for more timely and accurate data to inform policy and intervention strategies. Enhanced data collection efforts are essential for understanding and mitigating the opioid crisis. Corresponding Author: To contact the corresponding author, David Powell, PhD, email dpowell@rand.org. To ...

LAST 30 PRESS RELEASES:

The greater a woman’s BMI in early pregnancy, the more likely her child is to develop overweight or obesity, Australian study finds

The combination of significant weight gain and late motherhood greatly increases a woman’s risk of breast cancer, UK study finds

Weight-loss drugs cut alcohol intake by almost two-thirds, research in Ireland suggests

Swedish study explores differences in how the sexes break down fat

Antibiotics taken during infancy linked to early puberty in girls

Real-world evidence links long-term use of oral and inhaled steroids to adrenal insufficiency

Phthalates may impact key genital measurement in 3-year-olds

Phosphate levels in blood strongly affect sperm quality in men

Testosterone during pregnancy linked to physical activity and muscle strength in children

Menopause at an earlier age increases risk of fatty liver disease and metabolic disorders

Early-life growth proved important for height in puberty and adulthood

Women with infertility history at greater risk of cardiovascular disease after assisted conception

UO researcher develops new tool that could aid drug development

Call for abstracts: GSA Connects 2025 invites geoscientists to share groundbreaking research

The skinny on fat, ascites and anti-tumor immunity

New film series 'The Deadly Five' highlights global animal infectious diseases

Four organizations receive funds to combat food insecurity

Ultrasound unlocks a safer, greener way to make hydrogels 

Antibiotics from human use are contaminating rivers worldwide, study shows

A more realistic look at DNA in action

Skia: Shedding light on shadow branches

Fat-rich fluid fuels immune failure in ovarian cancer

The origins of language

SNU-Harvard researchers jointly build next-gen swarm robots using simple linked particles

First fossil evidence of endangered tropical tree discovered

New gene linked to severe cases of Fanconi anemia

METTL3 drives oral cancer by blocking tumor-suppressing gene

Switch to two-point rating scales to reduce racism in performance reviews, research suggests

The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: May 9, 2025

Stability solution brings unique form of carbon closer to practical application

[Press-News.org] METTL3 drives oral cancer by blocking tumor-suppressing gene
“[…] we report that METTL3, an oncogene regulates the expression of SMAD4, a tumor-suppressor via miR-146a-5p, thus unveiling a novel regulatory axis of METTL3/miR-146a-5p/SMAD4 in OSCC, which can potentially have therapeutic implications”